Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mallinckrodt
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has severe or recalcitrant keratitis
Did not respond to, or tolerate, treatment with topical cyclosporine, Lifitegrast, or any immunosuppressant to treat keratitis
If able to reproduce, agrees to use 2 forms of effective contraception with a partner of the opposite sex for the duration of the study (through Visit 6)
Has normal eyelids, and protocol-defined physical and medical eye attributes
Agrees to avoid wearing contact lenses during the trial
You may not be if
Is pregnant or breast-feeding
Is defined as vulnerable, or is employed by, or related to anyone involved in the study
Has a medical condition or history that might, per protocol or in the opinion of the investigator, compromise the participant's safety or study analysis
Clareo Health | Impact of Acthar on Everyday Life of Participants With Severe Keratitis
